Literature DB >> 14637086

A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy.

Andrew Grover1, Elisabet England, Mathew Baker, Naruhiko Sahara, Jennifer Adamson, Brian Granger, Henry Houlden, Ulla Passant, Shu-Hui Yen, Michael DeTure, Michael Hutton.   

Abstract

A novel mutation in exon 9 of tau, I260V, is associated with a clinical syndrome consistent with frontotemporal dementia with extensive tau pathology; however, neurofibrillary tangles and Pick bodies are absent. Significantly, Sarkosyl-insoluble tau extracted from affected brain tissue consisted almost exclusively of four-repeat isoforms. Consistent with these findings, in vitro biochemical assays demonstrated that the I260V mutation causes a selective increase in tau aggregation and a decrease in tau-induced microtubule assembly with four-repeat isoforms only. The contrasting pathology and biochemical effects of this mutation suggest a different disease mechanism from the other exon 9 mutations and demonstrates the critical role for the first microtubule-binding domain in tau-promoted microtubule assembly and the pathogenic aggregation of tau.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637086     DOI: 10.1016/s0014-4886(03)00393-5

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

1.  Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia.

Authors:  Manuela Neumann; Silvia Diekmann; Uwe Bertsch; Ben Vanmassenhove; Bernhard Bogerts; Hans A Kretzschmar
Journal:  Neurogenetics       Date:  2005-03-12       Impact factor: 2.660

Review 2.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

3.  Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.

Authors:  Naomi Kouri; Yari Carlomagno; Matthew Baker; Amanda M Liesinger; Richard J Caselli; Zbigniew K Wszolek; Leonard Petrucelli; Bradley F Boeve; Joseph E Parisi; Keith A Josephs; Ryan J Uitti; Owen A Ross; Neill R Graff-Radford; Michael A DeTure; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2014-02       Impact factor: 17.088

4.  Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps.

Authors:  Edward Chang; Sohee Kim; Haishan Yin; Haikady N Nagaraja; Jeff Kuret
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

5.  Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Authors:  Emilia M Gatto; Ricardo F Allegri; Gustavo Da Prat; Patricio Chrem Mendez; David S Hanna; Michael O Dorschner; Ezequiel I Surace; Cyrus P Zabetian; Ignacio F Mata
Journal:  Neurobiol Aging       Date:  2017-02-10       Impact factor: 4.673

6.  Unlocking truths of γ-secretase in Alzheimer's disease: what is the translational potential?

Authors:  Michael S Wolfe
Journal:  Future Neurol       Date:  2014

Review 7.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

Review 8.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Authors:  B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

Review 9.  A network of RNA and protein interactions in Fronto Temporal Dementia.

Authors:  Francesca Fontana; Kavitha Siva; Michela A Denti
Journal:  Front Mol Neurosci       Date:  2015-03-19       Impact factor: 5.639

Review 10.  The role of tau in neurodegenerative diseases and its potential as a therapeutic target.

Authors:  Michael S Wolfe
Journal:  Scientifica (Cairo)       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.